Oral mucositis (OM) is one of the most impacting oral complications negatively affecting the quality of life of cancer patients being treated with high-dose chemotherapy and radiation of the head and neck. It is an acute adverse effect that can be devastating and could affect cancer prognosis. ...
Oral mucositis is a debilitating and dose limiting side effect of oncotherapy in cancer patients. Low Level Laser Therapy (LLLT) is a promising new intervention for the treatment of oral mucositis. Aims and OBJECTIVES: 1. perform a systematic review of available litera-ture on the therapeutic eff...
Jeannie Woith, BSN, RN, LMT, The James Cancer Hospital, The Ohio State University, discusses the treatment of oral mucositis in patients with head and neck cancer.Jeannie Woith, BSN, RN, LMT, The James Cancer Hospital, The Ohio State University, discusses the treatment of ora...
PURPOSE: Pain is a prominent symptom in radiotherapy-induced oral mucositis (OM). This study assesses the effect of pharmacological treatment in head and neck cancer patients with OM-induced pain and swallowing difficulties. METHODS: This study included 82 patients with head and neck cancer undergoin...
Liu X, Lorusso P, Mita M, Piha-Paul S, Hong DS, Fu S, et al. Incidence of mucositis in patients treated with temsirolimus-based regimens and correlation to treatment response. The oncologist. 2014; 19 (4):426-8. https://doi.org/10.1634/theoncologist.2013-0231 PMID: 24668327;...
Mucositis is an inflammation of the oral and gastrointestinal mucosa, often associated with the administration of high-dose chemotherapy and radiotherapy regimens for cancer. It can be very debilitating, and in its most severe form can result in patients being unable to drink or swallow. It is ...
Mucositis study section of the multinational association for supportive care in cancer; international society for oral oncology. Perspectives on cancer the... Mucositis is a highly significant, and sometimes dose-limiting, toxicity of cancer therapy. The goal of this systematic review was to update ...
Disclosed are compositions and methods for alleviating mucositis, wherein said methods and compositions are directed to the formulation or use of selected nucleoside derivatives, especially ADP-ribose, that conform to the general formula A-B-X and pharmaceutically acceptable salts thereof, wherein “A...
Clinical practice guidelines for the prevention and treatment of cancer therapy‐induced oral and gastrointestinal mucositis. Cancer. 2004;100(9 Suppl):2026–46 The original article to which this Erratum refers was published in Cancer (2001) (2004) 100(9 Suppl):2026–46 . None - 《Cancer》 ...
Alimentary tract (AT) mucositis can be a major problem for patients undergoing cancer treatment. It has significant clinical and economic consequences and is a major factor that can compromise the provision of optimal treatment for patients. The pathobiology of AT mucositis is complex and the exact...